LRCX: Lam Research Corporation Financials
Lam Research Corporation Income Statement
Total revenue
Net income
Gross margin TTM
48.71%
Operating margin TTM
32.01%
Net profit margin TTM
29.06%
Return on investment TTM
54.33%
| Period end | 29/06/2025 | 30/06/2024 | 25/06/2023 | 26/06/2022 |
|---|---|---|---|---|
| Total revenue | 18,435,591,000 | 14,905,386,000 | 17,426,706,000 | 17,227,039,000 |
| Operating income | 5,900,968,000 | 4,263,913,000 | 5,174,860,000 | 5,381,822,000 |
| Net income | 5,358,217,000 | 3,827,772,000 | 4,510,931,000 | 4,605,286,000 |
All line items
| Line item | 29/06/2025 | 30/06/2024 | 25/06/2023 | 26/06/2022 |
|---|---|---|---|---|
| Total revenue | 18,435,591,000 | 14,905,386,000 | 17,426,706,000 | 17,227,039,000 |
| Cost of revenue | 9,456,532,000 | 7,852,595,000 | 9,651,591,000 | 9,355,232,000 |
| Gross profit | 8,979,059,000 | 7,052,791,000 | 7,776,925,000 | 7,871,807,000 |
| Research and development expenses | 2,096,387,000 | 1,902,444,000 | 1,727,162,000 | 1,604,248,000 |
| General and administrative expenses | 0 | 0 | 0 | 0 |
| Selling and marketing expenses | 0 | 0 | 0 | 0 |
| Selling, general and administrative expenses | 981,704,000 | 868,247,000 | 832,753,000 | 885,737,000 |
| Other expenses | 0 | 18,187,000 | 42,150,000 | 0 |
| Operating expenses | 3,078,091,000 | 2,788,878,000 | 2,602,065,000 | 2,489,985,000 |
| Cost and expenses | 12,534,623,000 | 10,641,473,000 | 12,253,656,000 | 11,845,217,000 |
| Net interest income | 53,128,000 | 66,702,000 | -47,478,000 | -169,550,000 |
| Interest income | 231,331,000 | 251,938,000 | 138,984,000 | 15,209,000 |
| Interest expense | 178,203,000 | 185,236,000 | 186,462,000 | 184,759,000 |
| Depreciation and amortization | 386,277,000 | 359,699,000 | 342,432,000 | 333,739,000 |
| EBITDA | 6,344,406,000 | 4,905,157,000 | 5,638,104,000 | 5,711,612,000 |
| EBIT | 5,958,129,000 | 4,545,458,000 | 5,295,672,000 | 5,377,873,000 |
| Non-operating income (excl. interest) | -57,161,000 | -281,545,000 | -120,812,000 | 3,949,000 |
| Operating income | 5,900,968,000 | 4,263,913,000 | 5,174,860,000 | 5,381,822,000 |
| Total other income/expenses (net) | 57,161,000 | 96,309,000 | -65,650,000 | -188,708,000 |
| Income before tax | 5,958,129,000 | 4,360,222,000 | 5,109,210,000 | 5,193,114,000 |
| Income tax expense | 599,912,000 | 532,450,000 | 598,279,000 | 587,828,000 |
| Net income from continuing operations | 5,358,217,000 | 3,827,772,000 | 4,510,931,000 | 4,605,286,000 |
| Net income from discontinued operations | 0 | 0 | 0 | 0 |
| Other adjustments to net income | 0 | 0 | 0 | 0 |
| Net income | 5,358,217,000 | 3,827,772,000 | 4,510,931,000 | 4,605,286,000 |
| Net income deductions | 0 | 0 | 0 | 0 |
| Bottom line net income | 5,358,217,000 | 3,827,772,000 | 4,510,931,000 | 4,605,286,000 |
| EPS | 4 | 3 | 3 | 3 |
| Diluted EPS | 4 | 3 | 3 | 3 |
| Weighted average shares outstanding | 1,286,101,000 | 1,314,100,000 | 1,354,720,000 | 1,398,990,000 |
| Weighted average diluted shares outstanding | 1,290,142,000 | 1,319,950,000 | 1,358,340,000 | 1,406,280,000 |
Lam Research Corporation Balance Sheet
Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
3,719,694,000%
Total debt / assets MRQ
—
| Period end | 29/06/2025 | 30/06/2024 | 25/06/2023 | 26/06/2022 |
|---|---|---|---|---|
| Total assets | 21,345,260,000 | 18,744,728,000 | 18,781,643,000 | 17,195,632,000 |
| Total liabilities | 11,483,641,000 | 10,205,274,000 | 10,571,471,000 | 10,917,266,000 |
| Total equity | 9,861,619,000 | 8,539,454,000 | 8,210,172,000 | 6,278,366,000 |
All line items
| Line item | 29/06/2025 | 30/06/2024 | 25/06/2023 | 26/06/2022 |
|---|---|---|---|---|
| Cash and cash equivalents | 6,390,659,000 | 5,847,856,000 | 5,337,056,000 | 3,522,001,000 |
| Short-term investments | 0 | 0 | 37,641,000 | 135,731,000 |
| Cash and short-term investments | 6,390,659,000 | 5,847,856,000 | 5,374,697,000 | 3,657,732,000 |
| Net receivables | 3,378,071,000 | 2,519,250,000 | 2,823,376,000 | 4,313,818,000 |
| Accounts receivable | 3,378,071,000 | 2,519,250,000 | 2,823,376,000 | 4,313,818,000 |
| Other receivables | 0 | 0 | 0 | 0 |
| Inventory | 4,307,991,000 | 4,217,924,000 | 4,816,190,000 | 3,966,294,000 |
| Prepaid expenses | 0 | 0 | 251,790,000 | 347,391,000 |
| Other current assets | 440,274,000 | 298,190,000 | -37,641,000 | 0 |
| Total current assets | 14,516,995,000 | 12,883,220,000 | 13,228,412,000 | 12,285,235,000 |
| Property, plant and equipment (net) | 2,428,744,000 | 2,154,518,000 | 1,856,672,000 | 1,647,587,000 |
| Goodwill | 1,626,485,000 | 1,626,528,000 | 1,622,489,000 | 1,515,113,000 |
| Intangible assets | 182,200,000 | 138,545,000 | 168,454,000 | 101,850,000 |
| Goodwill and intangible assets | 1,808,685,000 | 1,765,073,000 | 1,790,943,000 | 1,616,963,000 |
| Long-term investments | 16,997,000 | 2,947,000 | 0 | 0 |
| Tax assets | 0 | 0 | 0 | 0 |
| Other non-current assets | 2,573,839,000 | 1,938,970,000 | 1,905,616,000 | 1,645,847,000 |
| Total non-current assets | 6,828,265,000 | 5,861,508,000 | 5,553,231,000 | 4,910,397,000 |
| Other assets | 0 | 0 | 0 | 0 |
| Total assets | 21,345,260,000 | 18,744,728,000 | 18,781,643,000 | 17,195,632,000 |
| Total payables | 1,687,615,000 | 1,061,571,000 | 1,162,599,000 | 1,682,424,000 |
| Accounts payable | 854,208,000 | 613,966,000 | 470,702,000 | 1,011,208,000 |
| Other payables | 833,407,000 | 447,605,000 | 691,897,000 | 671,216,000 |
| Accrued expenses | 0 | 0 | 0 | 0 |
| Short-term debt | 749,670,000 | 501,316,000 | 421,000 | 0 |
| Capital lease obligations (current) | 83,348,000 | 3,498,000 | 7,937,000 | 7,381,000 |
| Tax payables | 0 | 186,700,000 | 885,348,000 | 465,601,000 |
| Deferred revenue | 2,565,540,000 | 1,417,781,000 | 1,695,221,000 | 1,571,898,000 |
| Other current liabilities | 1,482,252,000 | 1,354,272,000 | 1,318,740,000 | 1,303,056,000 |
| Total current liabilities | 6,568,425,000 | 4,338,438,000 | 4,184,918,000 | 4,564,759,000 |
| Long-term debt | 3,719,694,000 | 4,466,045,000 | 4,964,944,000 | 4,962,459,000 |
| Capital lease obligations (non-current) | 203,843,000 | 12,475,000 | 38,239,000 | 35,990,000 |
| Deferred revenue (non-current) | 0 | 0 | 0 | 0 |
| Deferred tax liabilities (non-current) | 0 | 0 | 0 | 0 |
| Other non-current liabilities | 991,679,000 | 1,388,316,000 | 1,383,370,000 | 1,354,058,000 |
| Total non-current liabilities | 4,915,216,000 | 5,866,836,000 | 6,386,553,000 | 6,352,507,000 |
| Other liabilities | 0 | 0 | 0 | 0 |
| Capital lease obligations | 287,191,000 | 15,973,000 | 46,176,000 | 43,371,000 |
| Total liabilities | 11,483,641,000 | 10,205,274,000 | 10,571,471,000 | 10,917,266,000 |
| Treasury stock | -27,763,430,000 | -24,366,866,000 | -21,530,353,000 | -19,481,429,000 |
| Preferred stock | 0 | 0 | 0 | 0 |
| Common stock | 1,268,000 | 130,000 | 133,000 | 137,000 |
| Retained earnings | 28,988,914,000 | 24,811,315,000 | 22,032,096,000 | 18,454,724,000 |
| Additional paid-in capital | 8,697,290,000 | 8,225,303,000 | 7,809,002,000 | 7,414,916,000 |
| Accumulated other comprehensive income/loss | -62,423,000 | -130,428,000 | -100,706,000 | -109,982,000 |
| Other stockholders' equity | 0 | 0 | 0 | 0 |
| Total stockholders' equity | 9,861,619,000 | 8,539,454,000 | 8,210,172,000 | 6,278,366,000 |
| Total equity | 9,861,619,000 | 8,539,454,000 | 8,210,172,000 | 6,278,366,000 |
| Minority interest | 0 | 0 | 0 | 0 |
| Total liabilities and total equity | 21,345,260,000 | 18,744,728,000 | 18,781,643,000 | 17,195,632,000 |
| Total investments | 16,997,000 | 2,947,000 | 37,641,000 | 135,731,000 |
| Total debt | 4,756,555,000 | 4,983,334,000 | 5,011,541,000 | 5,005,830,000 |
| Net debt | -1,634,104,000 | -864,522,000 | -325,515,000 | 1,483,829,000 |
Lam Research Corporation Cash Flow Statement
Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
| Period end | 29/06/2025 | 30/06/2024 | 25/06/2023 | 26/06/2022 |
|---|---|---|---|---|
| Cash from operations | 6,173,264,000 | 4,652,269,000 | 5,178,938,000 | 3,099,674,000 |
| Cash from investing | -708,092,000 | -370,614,000 | -534,562,000 | 612,275,000 |
| Cash from financing | -4,936,643,000 | -3,995,850,000 | -2,830,667,000 | -4,578,937,000 |
| Net change in cash | 556,853,000 | 263,431,000 | 1,813,837,000 | -897,215,000 |
All line items
| Line item | 29/06/2025 | 30/06/2024 | 25/06/2023 | 26/06/2022 |
|---|---|---|---|---|
| Net income | 5,358,217,000 | 3,827,772,000 | 4,510,931,000 | 4,605,286,000 |
| Depreciation and amortization | 386,277,000 | 359,699,000 | 342,432,000 | 333,739,000 |
| Deferred income tax | -363,247,000 | -198,981,000 | -172,061,000 | -257,438,000 |
| Stock-based compensation | 343,371,000 | 293,058,000 | 286,600,000 | 259,064,000 |
| Change in working capital | 441,801,000 | 360,478,000 | 158,738,000 | -1,796,226,000 |
| Accounts receivable | -858,748,000 | 303,443,000 | 1,452,256,000 | -1,287,680,000 |
| Inventory | -180,733,000 | 528,723,000 | -961,968,000 | -1,351,344,000 |
| Accounts payable | 212,000,000 | 125,939,000 | -522,200,000 | 167,884,000 |
| Other working capital | 1,269,282,000 | -597,627,000 | 190,650,000 | 674,914,000 |
| Other non-cash items | 6,845,000 | 10,243,000 | 52,298,000 | -44,751,000 |
| Net cash from operating activities | 6,173,264,000 | 4,652,269,000 | 5,178,938,000 | 3,099,674,000 |
| Investments in property, plant and equipment | -759,186,000 | -396,670,000 | -501,568,000 | -546,034,000 |
| Acquisitions (net) | 0 | 0 | -119,955,000 | 0 |
| Purchases of investments | 0 | 0 | -98,132,000 | -567,819,000 |
| Sales/maturities of investments | 0 | 37,766,000 | 98,132,000 | 1,733,703,000 |
| Other investing activities | 51,094,000 | -11,710,000 | 86,961,000 | -7,575,000 |
| Net cash from investing activities | -708,092,000 | -370,614,000 | -534,562,000 | 612,275,000 |
| Net debt issuance | -507,488,000 | -256,104,000 | -23,206,000 | -11,889,000 |
| Long-term net debt issuance | -507,488,000 | -256,104,000 | -23,206,000 | -11,889,000 |
| Short-term net debt issuance | 0 | 0 | 0 | 0 |
| Net stock issuance | -3,279,756,000 | -2,827,254,000 | -2,005,901,000 | -3,859,981,000 |
| Net common stock issuance | -3,279,756,000 | -2,827,254,000 | -2,005,901,000 | -3,859,981,000 |
| Common stock issuance | 142,565,000 | 15,553,000 | 11,111,000 | 5,682,000 |
| Common stock repurchased | -3,422,321,000 | -2,842,807,000 | -2,017,012,000 | -3,865,663,000 |
| Net preferred stock issuance | 0 | 0 | 0 | 0 |
| Net dividends paid | -1,149,542,000 | -1,018,915,000 | -907,907,000 | -815,290,000 |
| Common dividends paid | -1,149,542,000 | -1,018,915,000 | -907,907,000 | -815,290,000 |
| Preferred dividends paid | 0 | 0 | 0 | 0 |
| Other financing activities | 143,000 | 106,423,000 | 106,347,000 | 108,223,000 |
| Net cash from financing activities | -4,936,643,000 | -3,995,850,000 | -2,830,667,000 | -4,578,937,000 |
| Effect of FX changes on cash | 28,324,000 | -22,374,000 | 128,000 | -30,227,000 |
| Net change in cash | 556,853,000 | 263,431,000 | 1,813,837,000 | -897,215,000 |
| Cash at end of period | 6,407,656,000 | 5,850,803,000 | 5,587,372,000 | 3,773,535,000 |
| Cash at beginning of period | 5,850,803,000 | 5,587,372,000 | 3,773,535,000 | 4,670,750,000 |
| Operating cash flow | 6,173,264,000 | 4,652,269,000 | 5,178,938,000 | 3,099,674,000 |
| Capital expenditure | -759,186,000 | -396,670,000 | -501,568,000 | -546,034,000 |
| Free cash flow | 5,414,078,000 | 4,255,599,000 | 4,677,370,000 | 2,553,640,000 |
| Income taxes paid | 972,513,000 | 991,821,000 | 809,748,000 | 807,669,000 |
| Interest paid | 172,355,000 | 173,094,000 | 174,745,000 | 175,528,000 |